Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
CIR S.p.A. – Compagnie Industriali Riunite is a listed Italian holding company that invests in key sectors of the real economy with an entrepreneurial, selective, and long-term approach. Founded in 1976 and listed on the Italian stock exchange in the FTSE Italia Mid Cap segment, it focuses primarily on healthcare and automotive components through its main subsidiaries, KOS and Sogefi. KOS leads in nursing homes for non-self-sufficient elderly, functional and psychiatric rehabilitation, managing 13,777 beds and operating in Italy and Germany. Sogefi, a key supplier to major car manufacturers, specializes in suspensions, air and cooling systems, with 24 industrial sites across 14 countries. CIR also handles financial management via CIR Investimenti, maintaining a prudent, diversified portfolio. Controlled by Fratelli De Benedetti S.p.A. and led by CEO Monica Mondardini since 2013, the group generated €1,821 million in revenues in 2024, employs 15,054 people across 14 countries, and emphasizes ESG values to drive sustainable growth and value creation for stakeholders.
Operating margin is thin at 7.59%. Limited cushion if revenue slows or costs rise, not the profile of a wide-moat business.
Revenue declined 1.1% YoY. The question is whether this is cyclical or a structural shift.
Net debt of €642M represents 5.8x FCF, leverage limits flexibility.
Profitability & Returns
Revenue (TTM)
€1.80B
▼ -1.1% YoY
Net Income (TTM)
€49M
▼ -75.4% YoY
Op. Margin
7.59%
▲ +1.3pp YoY
ROIC
4.09%
▲ +0.7pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
€111M
▲ +45.3% YoY
Op. Cash Flow (TTM)
€226M
▲ +35.1% YoY
Net Debt
€642M
Cash & Equiv.
€416M
3Y CAGR: -6.8%
3Y CAGR: +16.4%
Continue Research